Treatment of lobar atelectasis with bronchoscopically administered recombinant human deoxyribonuclease in cystic fibrosis?
- PMID: 20298317
- DOI: 10.1111/j.1752-699X.2007.00024.x
Treatment of lobar atelectasis with bronchoscopically administered recombinant human deoxyribonuclease in cystic fibrosis?
Abstract
Introduction: Recombinant human deoxyribonuclease (rhDNase) reduces sputum viscosity and improves pulmonary function in cystic fibrosis (CF).
Objective: The objective of this study was to describe our experience in which rhDNase (Pulmozyme; Roche, Basel, Switzerland) was administered by bronchoscopic instillation into atelectatic lobes in five adults with CF.
Conclusion: We found this method successful in treating lobar atelectasis, which was resistant to conventional therapy with antibiotics and physiotherapy. In all but one of the cases we described, administration of DNase in this manner resulted in a radiographic and clinical improvement of the atelectasis. We recommend that respiratory physicians consider this as a second line treatment in the management of atelectasis.
Similar articles
-
Bronchoscopically administered recombinant human DNase for lobar atelectasis in cystic fibrosis.Pediatr Pulmonol. 2001 May;31(5):383-8. doi: 10.1002/ppul.1062. Pediatr Pulmonol. 2001. PMID: 11340685
-
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.N Engl J Med. 1994 Sep 8;331(10):637-42. doi: 10.1056/NEJM199409083311003. N Engl J Med. 1994. PMID: 7503821 Clinical Trial.
-
Easy removal of a large mucus plug with a flexible paediatric bronchoscope after administration of rhDNase (Pulmozyme).Klin Padiatr. 2006 Mar-Apr;218(2):88-91. doi: 10.1055/s-2005-836608. Klin Padiatr. 2006. PMID: 16506110
-
[Recombinant human DNase in conditions other than cystic fibrosis].Ugeskr Laeger. 2010 Feb 22;172(8):616-9. Ugeskr Laeger. 2010. PMID: 20184817 Review. Danish.
-
[Pharmacological and clinical profiles of Dornase alfa (Pulmozyme®) in the management of cystic fibrosis patients to improve pulmonary function].Nihon Yakurigaku Zasshi. 2013 Apr;141(4):213-9. doi: 10.1254/fpj.141.213. Nihon Yakurigaku Zasshi. 2013. PMID: 23575427 Review. Japanese. No abstract available.
Cited by
-
A successful treatment of a lobar atelectasis in a patient with cystic fibrosis.Pediatr Pulmonol. 2022 Nov;57(11):2868-2871. doi: 10.1002/ppul.26094. Epub 2022 Sep 6. Pediatr Pulmonol. 2022. PMID: 36000266 Free PMC article.
-
Should atelectasis be considered a pulmonary complication and indicator of poor prognosis in cystic fibrosis?J Int Med Res. 2024 Mar;52(3):3000605241233520. doi: 10.1177/03000605241233520. J Int Med Res. 2024. PMID: 38546237 Free PMC article.
-
DNA and inflammatory mediators in bronchoalveolar lavage fluid from children with acute inhalational injuries.J Burn Care Res. 2013 May-Jun;34(3):326-33. doi: 10.1097/BCR.0b013e31825d5126. J Burn Care Res. 2013. PMID: 23128126 Free PMC article.
-
Flexible bronchoscopy in children: Utility and complications.Int J Pediatr Adolesc Med. 2016 Mar;3(1):18-27. doi: 10.1016/j.ijpam.2015.12.003. Epub 2016 Jan 28. Int J Pediatr Adolesc Med. 2016. PMID: 30805463 Free PMC article.
-
Acute Total Lung Collapse in a Woman with Acute Stroke and Atrial Fibrillation.J Clin Diagn Res. 2017 Feb;11(2):OJ07-OJ08. doi: 10.7860/JCDR/2017/23929.9413. Epub 2017 Feb 1. J Clin Diagn Res. 2017. PMID: 28384924 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
